Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jifa Zhang

Showing results (41-50 of 113) with videos related to

Pageof 12
Sort By:
European Journal of Medicinal Chemistry|April 6, 2023
Small molecule LpxC inhibitors against gram-negative bacteria: Advances and future perspectivesZhendong Niu, Peng Lei, Yuxi Wang, et al.
Future Medicinal Chemistry|March 31, 2023
Novel targeted protein degradation technologies as a therapeutic strategy for neurodegenerative diseasesChangyu Ren, Jiao Liu, Shiyun Pu, et al.
Journal of Medicinal Chemistry|May 10, 2023
Small-Molecule Modulators Targeting Toll-like Receptors for Potential Anticancer TherapeuticsJiayu Wang, Jifa Zhang, Jiaxing Wang, et al.
Journal of Medicinal Chemistry|February 6, 2023
Strategies of Targeting CK2 in Drug Discovery: Challenges, Opportunities, and Emerging ProspectsYijia Chen, Yuxi Wang, Jiaxing Wang, et al.
Acta Pharmaceutica Sinica. B|November 28, 2025
The epigenetic landscape of rheumatoid arthritis: Pathogenesis and drug therapeutic potentialsChengcheng Huang, Yuxiang Liang, Yang Li, et al.
European Journal of Medicinal Chemistry|November 23, 2025
ALDH1A inhibitors: Research advances in cancer therapeuticsXianxian Zhao, Xiang Wen, Ji Chen, et al.
Acta Pharmaceutica Sinica. B|April 24, 2020
Targeting autophagy-related protein kinases for potential therapeutic purposeHonggang Xiang, Jifa Zhang, Congcong Lin, et al.
Signal Transduction and Targeted Therapy|August 22, 2024
Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategiesJifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Drug Discovery Today|April 26, 2024
Development and therapeutic implications of small molecular inhibitors that target calcium-related channels in tumor treatmentLinxi Zhang, Changyu Ren, Jiao Liu, et al.
European Journal of Medicinal Chemistry|February 12, 2022
Recent advances of human dihydroorotate dehydrogenase inhibitors for cancer therapy: Current development and future perspectivesLele Zhang, Jifa Zhang, Jiaxing Wang, et al.
Pageof 12

Showing results (41-50 of 113) with videos related to

Sort By:
Pageof 12
European Journal of Medicinal Chemistry|April 6, 2023
Small molecule LpxC inhibitors against gram-negative bacteria: Advances and future perspectivesZhendong Niu, Peng Lei, Yuxi Wang, et al.
Future Medicinal Chemistry|March 31, 2023
Novel targeted protein degradation technologies as a therapeutic strategy for neurodegenerative diseasesChangyu Ren, Jiao Liu, Shiyun Pu, et al.
Journal of Medicinal Chemistry|May 10, 2023
Small-Molecule Modulators Targeting Toll-like Receptors for Potential Anticancer TherapeuticsJiayu Wang, Jifa Zhang, Jiaxing Wang, et al.
Journal of Medicinal Chemistry|February 6, 2023
Strategies of Targeting CK2 in Drug Discovery: Challenges, Opportunities, and Emerging ProspectsYijia Chen, Yuxi Wang, Jiaxing Wang, et al.
Acta Pharmaceutica Sinica. B|November 28, 2025
The epigenetic landscape of rheumatoid arthritis: Pathogenesis and drug therapeutic potentialsChengcheng Huang, Yuxiang Liang, Yang Li, et al.
European Journal of Medicinal Chemistry|November 23, 2025
ALDH1A inhibitors: Research advances in cancer therapeuticsXianxian Zhao, Xiang Wen, Ji Chen, et al.
Acta Pharmaceutica Sinica. B|April 24, 2020
Targeting autophagy-related protein kinases for potential therapeutic purposeHonggang Xiang, Jifa Zhang, Congcong Lin, et al.
Signal Transduction and Targeted Therapy|August 22, 2024
Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategiesJifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Drug Discovery Today|April 26, 2024
Development and therapeutic implications of small molecular inhibitors that target calcium-related channels in tumor treatmentLinxi Zhang, Changyu Ren, Jiao Liu, et al.
European Journal of Medicinal Chemistry|February 12, 2022
Recent advances of human dihydroorotate dehydrogenase inhibitors for cancer therapy: Current development and future perspectivesLele Zhang, Jifa Zhang, Jiaxing Wang, et al.
Pageof 12